{{Rsnum
|rsid=5031016
|Gene=CYP2A6
|Chromosome=19
|position=40843869
|Orientation=minus
|GMAF=0.02801
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CYP2A6
}}{{PharmGKB
|RSID=rs5031016
|Name_s=CYP2A6:45948A>G
|Gene_s=CYP2A6
|Feature=
|Evidence=Web Resource:http://www.pharmgkb.org/search/annotatedGene/cyp2a6/variant.jsp
|Annotation=This variant affects heat stability and affects nicotine metabolism; part of the CYP2A6*7 and CYP2A6*10 haplotypes.
|Drugs=nicotine
|Drug Classes=
|Diseases=
|Curation Level=In-Depth
|PharmGKB Accession ID=PA161145199
}}

{{PMID Auto
|PMID=24357089
|Title=Genetic Polymorphisms of Metabolic Enzymes and the Pharmacokinetics of Indapamide in Taiwanese Subjects
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}